Mortality Risk of Hypnotics: Strengths and Limits of Evidence

@article{Kripke2015MortalityRO,
  title={Mortality Risk of Hypnotics: Strengths and Limits of Evidence},
  author={Daniel F. Kripke},
  journal={Drug Safety},
  year={2015},
  volume={39},
  pages={93-107}
}
  • D. Kripke
  • Published 1 February 2016
  • Psychology
  • Drug Safety
Sleeping pills, more formally defined as hypnotics, are sedatives used to induce and maintain sleep. In a review of publications for the past 30 years, descriptive epidemiologic studies were identified that examined the mortality risk of hypnotics and related sedative–anxiolytics. Of the 34 studies estimating risk ratios, odds ratios, or hazard ratios, excess mortality associated with hypnotics was significant (p < 0.05) in 24 studies including all 14 of the largest, contrasted with no studies… 
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
  • D. Kripke
  • Psychology, Medicine
    F1000Research
  • 2016
TLDR
Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.
  • D. Kripke
  • Psychology, Medicine
    F1000Research
  • 2016
TLDR
Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.
  • D. Kripke
  • Psychology, Medicine
    F1000Research
  • 2016
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new
What do hypnotics cost hospitals and healthcare?
  • D. Kripke
  • Medicine, Political Science
    F1000Research
  • 2017
TLDR
More research is needed to more accurately assess unnecessary and excessive hypnotics costs to providers and insurers, as well as financial and health damages to the patients themselves.
What do hypnotics cost hospitals and healthcare?
  • D. Kripke
  • Medicine, Psychology
    F1000Research
  • 2017
TLDR
More research is needed to more accurately assess unnecessary and excessive hypnotics costs to providers and insurers, as well as financial and health damages to the patients themselves.
What do hypnotics cost hospitals and healthcare? [version 2; referees: 2 approved]
TLDR
The author has done considerable work in assembling data relating the use of sedatives and hypnotic drugs to harmful outcomes and increased healthcare costs, and gathers a wealth of evidence associating the two.
Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults
TLDR
The outcomes of policies aimed at deprescribing sedative-hypnotic medication in community-dwelling older adults are explored and driving safety policies and jurisdiction-wide educational campaigns promoting non-drug alternatives appear most promising.
Pharmacological Management of Insomnia.
TLDR
A clinical review discusses the currently available medication options to treat insomnia, their mechanisms of action, dosing, and side effect profiles, and provides guidance on long-term management of hypnotics and the use of these medications in the elderly, those with medical comorbidities, and other special populations.
The terra incognita of insomnia therapy in the elderly
  • F. Pillmann
  • Medicine, Psychology
    Acta psychiatrica Scandinavica
  • 2020
TLDR
Although the analysis found some evidence for the effectiveness of benzodiazepines, antidepressants and z-drugs in elderly patients with insomnia, the overwhelming conclusion drawn by the authors was that there is a marked scarceness of data on the various interventions used to treat insomnia in this patient group.
...
...

References

SHOWING 1-10 OF 96 REFERENCES
Mortality Hazard Associated with Anxiolytic and Hypnotic Drug Use in the National Population Health Survey
  • G. Belleville
  • Psychology, Medicine
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2010
TLDR
Sedative drug use is associated with a small but significant increase in mortality risk, and physicians should systematically consider possibilities for nonpharmacological treatment of sleep disturbances and anxiety.
Is usage of hypnotics associated with mortality?
Hypnotics and mortality in an elderly general population: a 12-year prospective study
TLDR
Underlying psychiatric disorders appear to be the principal confounders of the observed association between hypnotic use and mortality risk in a large cohort of community-dwelling elderly, taking into account a wide range of potential competing risks.
Association between hypnotics use and increased mortality: causation or confounding?
TLDR
The increased use of BZZ with approaching death is consistent with increasing symptomatic treatment in terminal illness and is more likely to be due to confounding than to causality.
Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study
TLDR
In this large cohort of patients attending UK primary care, anxiolytic and hypnotic drugs were associated with significantly increased risk of mortality over a seven year period, after adjusting for a range of potential confounders.
Cohort study of the association of hypnotic use with mortality in postmenopausal women
TLDR
The association of hypnotic use with mortality and incident disease was greatly reduced after adjusting for baseline risk factors and these findings do not support a strong independent association of hypnosis use with most health outcomes.
Hypnotics' association with mortality or cancer: a matched cohort study
TLDR
Receiving hypnotic prescriptions was associated with greater than threefold increased hazards of death even when prescribed <18 pills/year, and this association held in separate analyses for several commonly used hypnotics and for newer shorter-acting drugs.
Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.
TLDR
Research is needed to objectively determine whether the use of hypnotics increases the risk of infections, and Immune compromise or esophageal reflux and aspiration should be studied as possible mechanisms.
Use of non-benzodiazepine sedative hypnotics and risk of falls in older men.
TLDR
Use of non-pharmacologic approaches to sleep disturbances may represent the safest approach to sleep difficulties in older adults and is associated with an increased risk of falls.
Greater incidence of depression with hypnotic use than with placebo
  • D. Kripke
  • Psychology, Medicine
    BMC psychiatry
  • 2007
TLDR
Modern hypnotics were associated with an increased incidence of depression in data released by the FDA, which suggests that when there is a risk of depression, hypnotics may be contra-indicated.
...
...